12 Week Evaluation of the Safety and Efficacy of 4 Dosing Strategies of CP-526,555 and Placebo for Smoking Cessation.
Completed · Phase 2
Conditions studied: Smoking Cessation
In brief
The purpose of the study is to measure the safety and efficacy of four dosing strategies of CP-526,555 for 12 weeks compared with placebo for smoking cessation. Post-treatment follow-up of smoking status to one year from randomization was performed in a non-treatment extension Protocol A3051018
Key facts
- Study ID
- NCT00150254
- Run by
- Pfizer
- People needed
- 625
- Starts
- 2001-09-01
- Expected to finish
- 2002-10-01
- Last updated by the study team
- 2007-06-04
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Subjects must have smoked on average of at least ten cigarettes per day during the past year
- Subjects must have no period of abstinence greater than three months in the past year
You may not qualify if…
- Subjects with any history of clinically significant cardiovascular disease
- Uncontrolled hypertension
Where it is running
- Pfizer Investigational Site — Los Angeles, California, United States
- Pfizer Investigational Site — San Bernardino, California, United States
- Pfizer Investigational Site — Upland, California, United States
- Pfizer Investigational Site — West Covina, California, United States
- Pfizer Investigational Site — Farmington, Connecticut, United States
- Pfizer Investigational Site — Jackson, Florida, United States
- Pfizer Investigational Site — Lexington, Kentucky, United States
- Pfizer Investigational Site — New Orleans, Louisiana, United States
- Pfizer Investigational Site — Jackson, Mississippi, United States
- Pfizer Investigational Site — Omaha, Nebraska, United States
- Pfizer Investigational Site — Cincinnati, Ohio, United States
- Pfizer Investigational Site — Portland, Oregon, United States
- Pfizer Investigational Site — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.